Levodropropizine

Levodropropizine

Levodropropizine syrup

Levodropropizine is a cough suppressant medication used primarily in the treatment of non-productive cough. It is a non-opioid antitussive agent that acts peripherally to reduce the cough reflex.

Pharmacology

Levodropropizine works by inhibiting the release of neurotransmitters involved in the cough reflex. Unlike opioid cough suppressants, it does not act on the central nervous system, which reduces the risk of sedation and addiction.

Mechanism of Action

Levodropropizine acts on the peripheral nervous system by modulating the activity of sensory neurons in the respiratory tract. It reduces the sensitivity of the cough receptors, thereby decreasing the frequency and intensity of coughing.

Clinical Use

Levodropropizine is indicated for the symptomatic treatment of dry cough in adults and children. It is often preferred in patients who are sensitive to the sedative effects of opioid-based cough suppressants.

Dosage and Administration

The typical dosage of levodropropizine for adults is 60 mg taken orally up to three times a day. For children, the dosage is adjusted based on body weight. It is important to follow the prescribed dosage to avoid potential side effects.

Side Effects

Common side effects of levodropropizine include nausea, dizziness, and gastrointestinal discomfort. Rarely, it may cause allergic reactions such as rash or itching.

Contraindications

Levodropropizine is contraindicated in patients with known hypersensitivity to the drug. It should be used with caution in patients with renal impairment or liver disease.

Related Pages

• Cough suppressant
• Non-productive cough
• Peripheral nervous system